MA
BIVIW

MYDA Advisors’s BioVie Inc Warrant BIVIW Stock Holding History

MYDA Advisors’s Portfolio BIVIW Stock Details BIVIW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$71.9K Sell
159,800
-9,113
-5% -$2.85K 0.01% 174
2026
Q1 		$52.4K Sell
168,913
-5,087
-3% -$1.46K 0.01% 144
2025
Q4 		$44.7K Sell
174,000
-1,000
-0.6% -$327 0.01% 135
2025
Q3 		$76.3K Buy
+175,000
New +$71.2K 0.02% 155

Other funds holding BIVIW

DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
WAM
Warberg Asset Management Winnetka, Illinois $551M AUM 34.68% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
PCM
Prelude Capital Management New York $1.37B AUM 71.68% 1-Year Est. Return
HCM
Heights Capital Management San Francisco, California $433M AUM 8.59% 1-Year Est. Return
AAG
Armstrong Advisory Group Needham, Massachusetts $1.64B AUM 19.37% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return

MYDA Advisors's BIVIW Position: Q2 2026 in Review

MYDA Advisors reduced its BioVie Inc Warrant (BIVIW) stake by 5.4% in Q2 2026, selling an estimated $2.85K and leaving 159,800 shares worth $71.9K. The position accounts for 0.01% of the portfolio, ranked #174.

MYDA Advisors first reported a position in BIVIW in Q3 2025 and has held it in 4 quarters since. The position peaked at $76.3K in Q3 2025. 8 funds tracked by Wall St. Rank hold BIVIW as of Q2 2026.

  • MYDA Advisors held 159,800 shares of BioVie Inc Warrant worth $71.9K as of Q2 2026.
  • MYDA Advisors sold 9,113 BioVie Inc Warrant shares in Q2 2026, an estimated $2.85K.
  • BioVie Inc Warrant made up 0.01% of MYDA Advisors's portfolio in Q2 2026, its #174 holding.
  • MYDA Advisors first reported a position in BioVie Inc Warrant in Q3 2025 and has held it in 4 quarters since.
  • MYDA Advisors's BioVie Inc Warrant position peaked at $76.3K in Q3 2025.
  • 8 funds tracked by Wall St. Rank held BioVie Inc Warrant as of Q2 2026.

Based on MYDA Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.